Rivaroxaban in Type 2 Myocardial Infarctions

Clinical trial NCT04838808 · COMPLETED

Trial details

NCT number: NCT04838808
Sponsor: University of Alberta
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Type II Myocardial Infarction

Start date: 2021-04-05
Primary completion: 2022-05-12
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.